In summary, using the combined approaches of live brain imaging, whole brain imaging, molecular manipulation, synaptic and vascular assessments, and motor function examination, this study provides initial evidence that a stroke-damaged brain at 6 months post-stroke could be repairable by pharmaceutical intervention—systemic administration of two hematopoietic growth factors, SCF + G-CSF. This evidence concerns the gene KITLG and stroke disorder.